Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial (Q56355520)

From Wikidata
Jump to navigation Jump to search
article by Richard S Finn et al published August 2018 in Journal of Hepatology
edit
Language Label Description Also known as
English
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
article by Richard S Finn et al published August 2018 in Journal of Hepatology

    Statements

    Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial (English)
    0 references
    0 references
    Richard S Finn
    0 references
    Philippe Merle
    0 references
    Alessandro Granito
    0 references
    Yi-Hsiang Huang
    0 references
    György Bodoky
    0 references
    Marc Pracht
    0 references
    Osamu Yokosuka
    0 references
    Olivier Rosmorduc
    0 references
    René Gerolami
    0 references
    Chiara Caparello
    0 references
    Roniel Cabrera
    0 references
    Charissa Chang
    0 references
    Weijing Sun
    0 references
    Marie-Aude LeBerre
    0 references
    Annette Baumhauer
    0 references
    Gerold Meinhardt
    0 references
    August 2018
    0 references
    69
    0 references
    2
    0 references
    353-358
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit